Artificial Intelligence Doctor. Ask me questions - www.abcfarma.net
User question:
Aveir VR LP — Management Decision
Question
What decision would you make from these four options (or suggest another) based on the spreadsheet showing the history of an Aveir VR leadless pacemaker?
Wait and watch.
Implant a new unicameral LP.
Upgrade to a bicameral leadless system removing the existent device.
Do not remove or remove the current LP and place a transvenous CSP (Conduction System Pacing) pacemaker.
Short Answer
Option 2 — retrieve the current Aveir VR and implant a new unicameral LP (at a better RV septal site)
is the most appropriate choice based on the spreadsheet trend, unless you also have a clear need for AV-synchrony or expect a high lifelong ventricular pacing burden—in which case see “When another option might be better.”
Why Option 2, based on your data
Capture threshold has doubled: from 1.5 V @ 0.4 ms (2024‑05‑08) to 3.0 V @ 0.4 ms (2025‑04‑01), entering a range that significantly erodes longevity.
Projected longevity dropped: approximately 8.0 → 4.5 years across those checks, consistent with the higher programmed output required for reliable capture.
Lead–myocardial interface otherwise acceptable: impedance moved from ~340 → 550 Ω (both within expected range) and sensing improved from ~2.7 → 4.0 mV (good), pointing to site-specific capture inefficiency rather than a global hardware problem.
Lifestyle considerations: with a high weekly activity load, a fresh VR positioned for a low threshold (<1.0 V @ 0.4 ms) preserves leadless benefits without introducing transvenous hardware.
Because Aveir VR is retrievable and the implant age is relatively short, repositioning via re‑implant is a direct way to restore low thresholds and device longevity.
When another option might be better
Option 4 — Transvenous CSP (His/LBB)
Expected high RV pacing burden (e.g., persistent nocturnal bradycardia with daytime brady/symptoms).
Need to preserve physiologic activation to protect LV function (HF risk, prior RV pacing–related dyssynchrony, or LV dysfunction).
Anticipated future atrial pacing/diagnostic needs where dual‑chamber flexibility is valuable.
Preference for easier generator exchanges, accepting venous/lead hardware.
Option 3 — Bicameral leadless (remove current)
Documented indication for AV synchrony (pacemaker syndrome, high‑grade AV block) while wishing to stay fully leadless.
Not recommended solely to fix a high RV threshold.
Option 1 — Wait & watch
Reasonable only if repeat testing shows the threshold is stable around ~3.0 V @ 0.4 ms with an adequate safety margin and acceptable longevity—otherwise risk of further erosion.
If chosen, use a short re‑check interval (weeks), not months.
Quick Decision Checklist (do now)
Repeat thresholds at different times of day and body temperatures, using the actual programmed output and pulse width; document the worst‑case value.
Check pacing percentage (esp. nocturnal) and any non‑capture episodes.
Address reversible drivers: electrolytes (K⁺/Mg²), body temperature, sleep/autonomic factors (screen for sleep‑disordered breathing).
If worst‑case threshold persists at ≥ 2.5–3.0 V @ 0.4 ms or is rising → Proceed with Option 2 (retrieve and re‑implant at a better site).
If you also need AV synchrony or anticipate high pacing burden/LV risk → consider Option 4 (CSP) or Option 3 (bicameral leadless) based on hardware preferences.